peramivir hydrate
A hydrate that is the trihydrate form of peramivir. Used for the treatment of acute uncomplicated influenza in patients 18 years and older who have been symptomatic for no more than two days.
Machine-generated and unreviewed. Identity, structure and cross-references come straight from ChEBI's and CARD's own data; no curator has signed off on this record yet.
Classification
Chemical structure
| Molecular formula | C15H28N4O4.4H2O |
|---|---|
| Charge | 0 |
| Average mass | 400.473 Da |
| Monoisotopic mass | 400.25331 Da |
| Source | ChEBI |
| InChIKey | UGTYTOKVOXBJBZ-LINPMSLLSA-N |
O.O.O.O.[H][C@@]1([C@@H](NC(C)=O)C(CC)CC)[C@H](O)[C@@H](C(=O)O)C[C@H]1NC(=N)N
InChI=1S/C15H28N4O4.4H2O/c1-4-8(5-2)12(18-7(3)20)11-10(19-15(16)17)6-9(13(11)21)14(22)23;;;;/h8-13,21H,4-6H2,1-3H3,(H,18,20)(H,22,23)(H4,16,17,19);4*1H2/t9-,10+,11+,12-,13+;;;;/m0..../s1
Also called
- RAPIVAB
- peramivir
- (1S,2S,3R,4R)-3-[(1S)-1-acetamido-2-ethylbutyl]-4-carbamimidamido-2-hydroxycyclopentane-1-carboxylic acid—water (1/3)
- Peramivir trihydrate
Cross-references
- cas:1041434-82-5
- reaxys:18582192
Drug registries
Patents and articles
Activity roles
- antiviral drug
CHEBI:36044 - EC 3.2.1.18 (exo-α-sialidase) inhibitor
CHEBI:52425
Source concepts
| Source | Native ID | Label | Minted CURIE | Version |
|---|---|---|---|---|
| CHEBI | CHEBI:85196 |
peramivir hydrate | antibioticmech:chebi-636332475c |
2026-08-30 |
Mechanism summary
- Mode of action
- VIRAL_RELEASE_INHIBITION host shared target
Curation history
-
SEEDED_FROM_SOURCES
Seeded from data/raw/ inventories (CHEBI)
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories